About

US-based, China-focused, speciality pharmaceutical company, SciClone Pharmaceutical, is a profitable commercial business with substantial work in the area of oncology, infectious diseases and cardiovascular, urological, respiratory and central nervous system disorders. Charles Meng leads the legal team, and brings more than 20 years of experience in compliance and legal affairs spanning multinational companies in the pharmaceuticals, high technology and electronics, and government services sectors. The legal department is responsible for facilitating business with pharmaceutical partners – something which is crucial to SciClone’s business of marketing multiple branded products in China which are therapeutically differentiated. The team successfully licenses products to drive the company’s long-term growth, understanding the complex regulatory requirements in both the US and China markets. They accomplish this by promoting and engaging in the highest standards of integrity and ethical behaviour throughout the organisation.